New York, Jan 22, 2026, 14:43 ET — Regular session underway.
- KVUE edged up about 2.2% to $17.77 in afternoon trading, recovering from a 1.2% drop on Wednesday
- The deal implies roughly $18.40 per Kenvue share, based on current KMB prices, leaving a spread of about $0.64
- Kimberly-Clark is set to release its earnings on Jan. 27, with the merger vote scheduled for Jan. 29
Kenvue Inc. shares rose about 2.2% to $17.77 on Thursday, recovering from a dip the previous day. By early afternoon, trading volume had already exceeded 43 million shares.
Investors continue to view KVUE as a vote-driven deal play. Kenvue and Kimberly-Clark shareholders are set to vote on the merger January 29, per filings. The offer includes $3.50 cash plus 0.14625 Kimberly-Clark shares for each Kenvue share. Kimberly-Clark’s stock climbed about 1.9% to $101.91, pushing the total value of the package to roughly $18.40 for Kenvue—about 64 cents above KVUE’s close on Thursday.
The gap is the merger-arbitrage spread — the difference between KVUE’s current trading price and the deal’s implied value. This spread tends to widen when investors fear delays or a possible deal collapse. If KMB’s shares rally, the spread narrows; a slide in KMB’s stock causes it to widen again.
Kenvue dropped 1.19% on Wednesday, closing at $17.38. The stock saw 40.6 million shares change hands, beating its 50-day average volume of 38.6 million, per MarketWatch data.
The broader market moved higher Thursday, with the SPDR S&P 500 ETF up roughly 0.8% and the Dow-focused ETF advancing about 0.9%. The consumer staples ETF edged down a bit, hinting that Kenvue’s surge was tied more to the deal than sector momentum.
In November, Kimberly-Clark and Kenvue announced their deal, targeting completion in the latter half of 2026, subject to approvals. Kenvue CEO Kirk Perry said the move “will bring greater value to our shareholders,” while board chair Larry Merlo highlighted the “significant upfront value” of the agreement. Kimberly-Clark CEO Mike Hsu called the plan one that creates “a global health and wellness leader.” Kenvue
But the anchor might snap. Should shareholders on either side spurn the deal, or if regulators and courts stall, KVUE stands to lose the takeover premium that’s been fueling its stock. That could send shares tumbling hard.
Kimberly-Clark will report its fourth-quarter and full-year 2025 results on Jan. 27. The company intends to release the materials around 6:30 a.m. ET, with an analyst Q&A scheduled for 8:00 a.m. ET.
With most of the deal tied to KMB stock, any sharp move in Kimberly-Clark’s shares after earnings could swiftly change the spread. Traders remain watchful for last-minute proxy filings, investor campaigns, or fresh legal updates before the Jan. 29 meetings.
KVUE’s trading is essentially a countdown. Keep an eye on Jan. 27, when Kimberly-Clark releases its earnings, and Jan. 29, the day shareholders vote on the merger. Those dates could make the spread tighten—or stretch out again.
Related articles: NYSE:KVUE
